Spontaneous Resolution in Autoimmune Pulmonary Alveolar Proteinosis: A Case Series.

IF 8.6 1区 医学 Q1 CRITICAL CARE MEDICINE
Chest Pub Date : 2025-06-01 DOI:10.1016/j.chest.2025.01.030
Shrimukta Sahoo, Puneet Saxena, Akhil K Ravi, Saurabh Tiwari, Valliappan Muthu, Ravi Charan Avala, Vishwanath Gella, Raghava Rao Gandra, Robin Choudhary
{"title":"Spontaneous Resolution in Autoimmune Pulmonary Alveolar Proteinosis: A Case Series.","authors":"Shrimukta Sahoo, Puneet Saxena, Akhil K Ravi, Saurabh Tiwari, Valliappan Muthu, Ravi Charan Avala, Vishwanath Gella, Raghava Rao Gandra, Robin Choudhary","doi":"10.1016/j.chest.2025.01.030","DOIUrl":null,"url":null,"abstract":"<p><p>Pulmonary alveolar proteinosis (PAP) is a rare lung condition characterized by the accumulation of proteinaceous material within the alveoli. The acquired form is often autoimmune, driven by autoantibodies against granulocyte-macrophage colony-stimulating factor. Presentation of autoimmune PAP may range from incidental detection in asymptomatic patients to advanced respiratory failure. Treatment typically involves whole lung lavage or granulocyte-macrophage colony-stimulating factor therapy in symptomatic patients; spontaneous resolution is rare in severe cases. Here, we report 3 cases of autoimmune PAP who presented with resting hypoxia and exhibited spontaneous resolution without significant treatment. All 3 cases had a history of occupational inhalational exposure to noxious gases, and they improved following sustained cessation of exposure. We hypothesize that occupational or environmental noxious inhalation exposure may have a role in disease expression in some cases of autoimmune PAP, and such cases may show spontaneous resolution following cessation of the offending exposure.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":"167 6","pages":"e177-e181"},"PeriodicalIF":8.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2025.01.030","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare lung condition characterized by the accumulation of proteinaceous material within the alveoli. The acquired form is often autoimmune, driven by autoantibodies against granulocyte-macrophage colony-stimulating factor. Presentation of autoimmune PAP may range from incidental detection in asymptomatic patients to advanced respiratory failure. Treatment typically involves whole lung lavage or granulocyte-macrophage colony-stimulating factor therapy in symptomatic patients; spontaneous resolution is rare in severe cases. Here, we report 3 cases of autoimmune PAP who presented with resting hypoxia and exhibited spontaneous resolution without significant treatment. All 3 cases had a history of occupational inhalational exposure to noxious gases, and they improved following sustained cessation of exposure. We hypothesize that occupational or environmental noxious inhalation exposure may have a role in disease expression in some cases of autoimmune PAP, and such cases may show spontaneous resolution following cessation of the offending exposure.

自身免疫性肺泡蛋白沉积症的自发消退:一个病例系列。
肺泡蛋白沉积症(PAP)是一种罕见的肺部疾病,其特征是肺泡内蛋白质物质的积累。获得性形式通常是自身免疫性的,由抗粒细胞-巨噬细胞集落刺激因子的自身抗体驱动。自身免疫性PAP的表现可能从无症状患者的偶然发现到晚期呼吸衰竭。治疗通常包括全肺灌洗或粒细胞-巨噬细胞集落刺激因子治疗;在严重的病例中,自发消退是罕见的。在这里,我们报告了3例自身免疫性PAP患者,他们表现为静息缺氧,并在未经显著治疗的情况下自行消退。3例均有职业性吸入有毒气体暴露史,持续停止接触后病情有所改善。我们假设职业性或环境性有害吸入暴露可能在某些自身免疫性PAP病例的疾病表达中起作用,并且这些病例可能在停止有害暴露后自发消退。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chest
Chest 医学-呼吸系统
CiteScore
13.70
自引率
3.10%
发文量
3369
审稿时长
15 days
期刊介绍: At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信